세계의 공간 전사체학 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

The global demand for Spatial Transcriptomics Market is presumed to reach the market size of nearly USD 1336.02 Million by 2032 from USD 383.97 Million in 2023 with a CAGR of 14.86% under the study period 2024-2032.

Spatial transcriptomics is an advanced technique that combines histology with transcriptomics to analyze gene expression within the spatial context of tissue sections. This method allows researchers to map the location of active genes in complex tissues, providing insights into cellular functions, interactions, and the microenvironment. Preserving spatial information helps to understand tissue architecture, identify distinct cellular niches, and study disease pathology at a granular level. This technology has significant applications in oncology, neuroscience, and developmental biology, enabling breakthroughs in understanding how gene expression varies across tissue regions.

MARKET DYNAMICS

The spatial transcriptomics market is being propelled by several influential factors shaping its growth trajectory. Firstly, advancements in genomic sequencing technologies and bioinformatics have revolutionized the field of transcriptomics, enabling researchers to study gene expression patterns within the spatial context of tissues and organs. This spatially resolved transcriptomic data provides valuable insights into cellular interactions, tissue architecture, and disease mechanisms, driving market growth. The growing adoption of single-cell analysis techniques and spatially resolved imaging modalities, such as multiplexed fluorescence in situ hybridization (FISH) and spatial transcriptomicsassays, enhances researchers' ability to explore complex biological systems at unprecedented resolution and scale. They are additionally increasing research investments and funding initiatives to understand spatial gene expression dynamics in health and disease fuel market expansion by supporting innovation and product development.

Moreover, rising applications of this technique in various fields, including oncology, neuroscience, developmental biology, and immunology, broaden market opportunities and drive interdisciplinary collaborations among academic institutions, biotechnology companies, and pharmaceutical firms. Furthermore, the integration of spatial transcriptomics data with other omics datasets, such as genomics, proteomics, and metabolomics, holds promise for comprehensive systems biology approaches and personalized medicine strategies, driving further market growth. However, the high cost of technology and the need for specialized expertise may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Spatial Transcriptomics. The growth and trends of Spatial Transcriptomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Spatial Transcriptomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Consumables
• Instruments
• Services

By Application

• Clinical
• Drug and Biomarker Discovery and Development

By End-user

• Academic Institutes
• Clinical and Life Science Laboratories
• Pharmaceutical and Biotechnology Companies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Spatial Transcriptomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Spatial Transcriptomics market include 10x Genomics Inc., NanoString Technologies Inc., Akoya Biosciences Inc., Bio-Techne Corporation, Bruker Corporation, Standard BioTools Inc. (Fluidigm), Vizgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. SPATIAL TRANSCRIPTOMICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Consumables Historic and Forecast Sales By Regions
• 5.4. Instruments Historic and Forecast Sales By Regions
• 5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Clinical Historic and Forecast Sales By Regions
• 6.4. Drug and Biomarker Discovery and Development Historic and Forecast Sales By Regions

7. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Academic Institutes Historic and Forecast Sales By Regions
• 7.4. Clinical and Life Science Laboratories Historic and Forecast Sales By Regions
• 7.5. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SPATIAL TRANSCRIPTOMICS COMPANIES

• 9.1. Spatial Transcriptomics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF SPATIAL TRANSCRIPTOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. 10x Genomics Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. NanoString Technologies Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Akoya Biosciences Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Bio-Techne Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Bruker Corporation
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Standard BioTools Inc. (Fluidigm)
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Vizgen Inc
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies